Results 21 to 30 of about 3,071,470 (305)

HPV IMMUNOHISTOCHEMICAL TESTING AND CERVICAL DYSPLASIA [PDF]

open access: yesMedicine and Pharmacy Reports, 2016
Background and aim. HPV (Human Papilloma Virus) infection represents a necessary condition for cervical carcinogenesis. The purpose of this study was to evaluate the efficiency of HPV testing using an immunohistochemical staining kit with implications upon both diagnosis and treatment of cervical intraepithelial neoplasia (CIN).Methods.
MUREŞAN, DANIEL   +4 more
openaire   +2 more sources

Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand

open access: yesObstetrics and Gynecology International, 2016
Objective. To evaluate the performance of high-risk human papillomavirus (HPV) DNA testing in urine samples compared to that of cervical sample testing in Northern Thailand. Methods.
Surapan Khunamornpong   +5 more
doaj   +1 more source

Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS

open access: yesBMC Cancer, 2019
Background Atypical squamous cell of undetermined significance (ASCUS) is a common cervical cytological diagnosis. At present, HPV DNA assay is used to triage these patients, but its lower specificity brings a series of problems.
Yuanhang Zhu   +5 more
doaj   +1 more source

Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting [PDF]

open access: yes, 2007
Objectives: To compare the performance and acceptability of unsupervised self-sampling with clinician sampling for high-risk human papillomavirus (HPV) types for the first time in a UK screening setting.
Austin, Janet   +17 more
core   +1 more source

Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study

open access: yesVirology Journal, 2019
Background We evaluated the prognostic and diagnostic ability of p16/Ki-67 immunocytochemistry, HPV E6/E7 mRNA testing and HPV DNA assay in triaging ASCUS to find a way to manage cervical lesions more effectively. Methods We conducted a prospective study
Chenchen Ren   +6 more
doaj   +1 more source

Statement on HPV DNA Test Utilization [PDF]

open access: yesActa Cytologica, 2009
Testing for carcinogenic or high-risk human papillomavirus (HPV) DNA has proven utility in cervical cancer screening and in many aspects of clinical management for cervical cancer prevention. However, inappropriate testing increases costs without benefit and potentially results in over-treatment of women.
Solomon, Diane   +2 more
openaire   +10 more sources

Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China’s largest independent operator of pathology laboratories

open access: yesBMC Infectious Diseases, 2019
Background High-risk human papillomavirus (HR-HPV) testing is more sensitive than cytology for the detection of cervical cancer and its precursors. However, limited and inconsistent data are available about the efficacy of the combination of these two ...
Fengxiang Xie   +10 more
doaj   +1 more source

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial

open access: yesCancer Medicine, 2021
The Human Papillomavirus FOr CervicAL cancer (HPV FOCAL) trial is a large randomized controlled trial comparing the efficacy of primary HPV testing to cytology among women in the population‐based Cervix Screening Program in British Columbia, Canada.
Ian Cromwell   +13 more
doaj   +1 more source

HPV testing statistics, National HPV testing pilot project, Kenya, 2020.

open access: yes, 2023
HPV testing statistics, National HPV testing pilot project, Kenya, 2020.
Marc Arbyn (151897)   +9 more
core   +1 more source

Informatics methods for laboratory evaluation of HPV ordering patterns with an example from a nationwide sample in the United States, 2003-2009

open access: yesJournal of Pathology Informatics, 2010
Background: Laboratory data is a rich source of information that can be used to estimate adherence to physician guidelines and motivate improvement in clinical practice.
Brian H Shirts, Brian R Jackson
doaj   +1 more source

Home - About - Disclaimer - Privacy